Cytotoxicity of dioscin in human gastric carcinoma cells through death receptor and mitochondrial pathways

Journal of Applied Toxicology : JAT
Ming-Ming HuXianyao Wan

Abstract

In the present study, the antiproliferative effect of dioscin on human gastric carcinoma SGC-7901 cells was confirmed by 3-(4, 5-dimethylthiahiazo-zyl)-2, 5-dip-henytetrazolium bromide and flow cytometry assays. Through acridine orange-ethidium bromide double fluorescent staining, apoptotic morphology of the cells was observed. Radioimmunoassays showed that the tumor necrosis factor (TNF)-α concentration in cells treated with dioscin significantly increased compared with untreated cells. Several proteins and mRNA related to the mitochondrial and death receptor pathways were investigated. We found that the expression of Bid, bcl-2 and bcl-xl was markedly downregulated, and the expression of Bak and Bax was upregulated. In addition, cytochrome c was released from the mitochondria into the cytosol, which indicates activation of the mitrochondrial pathway by dioscin. Furthermore, upregulation of Fas, FasL (Fas ligand), TNF-α, TNF receptor-1, TNF receptor-associated factor 1 and Fas-associated protein with death domain demonstrated involvement of the death receptor pathway. Increased mRNA expression of p53 was also found in dioscin-treated SGC-7901 cells, and the activation of caspase-3 and -8 was also observed. Consequently, this s...Continue Reading

References

May 1, 1990·Clinical Oncology : a Journal of the Royal College of Radiologists·K K Ketiku, A T Ajekigbe
Dec 1, 1985·European Journal of Cancer & Clinical Oncology·J A RadfordR D Rubens
Jun 1, 1995·Cancer Metastasis Reviews·J M Lee, A Bernstein
Jan 1, 1993·Cancer Chemotherapy and Pharmacology·N M LopesB K Bhuyan
Feb 10, 1997·FEBS Letters·M Van de CraenW Fiers
Mar 10, 2000·Biochemical and Biophysical Research Communications·S M KhanJ Yeh
Feb 21, 2002·Biological & Pharmaceutical Bulletin·Jing CaiYong Ju
Nov 29, 2002·International Journal of Hygiene and Environmental Health·Nachman Brautbar, John Williams
Dec 21, 2002·Molecular Immunology·Christoph Borner
Oct 14, 2003·Biochemical Pharmacology·Upasna Gaur, Bharat B Aggarwal
Nov 25, 2003·Oncogene·Alexei DegterevJunying Yuan
Feb 7, 2004·Planta medica·M SautourM-A Lacaille-Dubois
Mar 5, 2004·Biochimica Et Biophysica Acta·Martin R Sprick, Henning Walczak
Mar 10, 2004·Human Reproduction Update·Tamer M SaidAshok Agarwal
May 22, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Nikolai A MaianskiTaco W Kuijpers
Jul 17, 2004·Biological & Pharmaceutical Bulletin·Ming-Jie LiuRicky Ngok-Shun Wong
Dec 9, 2004·Biochimica Et Biophysica Acta·Jason O'NeillDavid M Hockenbery
Jun 21, 2005·Nature Reviews. Cancer·Shoshana KleinAlexander Levitzki
Nov 29, 2007·Current Opinion in Oncology·David S Ziegler, Andrew L Kung
Sep 10, 2008·Biochemical Pharmacology·Amir M Hossini, Jürgen Eberle
Oct 10, 2009·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·Yu-Bin JiXiang Zou
Oct 13, 2009·Bioorganic & Medicinal Chemistry·Matthew J KaskiwZi-Hua Jiang
Dec 1, 2009·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Gulbeyaz Can, Adnan Aydiner
Mar 9, 2010·Biochemical and Biophysical Research Communications·Shicheng LiuHitoshi Yamauchi
Jun 17, 2010·Fitoterapia·Shuli ManChangxiao Liu
Jan 5, 2011·European Journal of Pharmacology·Bu Tong SunYu Xin Li
Feb 8, 2011·Biochimica Et Biophysica Acta·Chahrazade Kantari, Henning Walczak

❮ Previous
Next ❯

Citations

Oct 23, 2013·Archives of Toxicology·Tingting XuJinyong Peng
Feb 6, 2014·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Jing ChenJin-Lan Ruan
Apr 29, 2014·Apoptosis : an International Journal on Programmed Cell Death·Eun-Ae KimTae-Jin Lee
Mar 13, 2016·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Xinwei ZhaoJinyong Peng
Aug 25, 2015·Molecular Medicine Reports·Zeliang WeiWen Huang
Sep 9, 2015·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Meng QiJinyong Peng
Apr 24, 2014·European Journal of Pharmacology·Ying WangJen-Fu Chiu
Jun 9, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Xinwei ZhaoJinyong Peng
Jul 20, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Meng QiJinyong Peng
Oct 19, 2016·BMC Complementary and Alternative Medicine·Ting MaXi Zou
Oct 27, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Xiao-Huang XuJin-Jian Lu
Apr 9, 2015·Scientific Reports·Xiaoling ZhangJinyong Peng
Feb 12, 2013·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Aijie ZhangKexin Liu
Nov 24, 2016·Frontiers in Plant Science·Sukhdev SinghAshok Kumar
Sep 9, 2019·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Qiaozhen KangJike Lu
Oct 14, 2020·Current Drug Targets·Shailaja Dombe, Pramodkumar Shirote

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Related Papers

Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
Linlin LvJin-Yong Peng
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
Yongli WeiJin-Yong Peng
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
Tingting XuJinyong Peng
© 2022 Meta ULC. All rights reserved